Effects of silencing KCa1.1 or Kir2.1 on cell proliferation in human cardiac c-kit⁺ progenitor cells. by Ying-Ying Zhang (586673)

Table 1_Coffee consumption as a double-edged sword for serum lipid profile: findings from NHANES 2005–2020.docx by Chaoyue Mo (21684056)

“…In females, HDL-C levels rose with coffee consumption up to 2.6 cups/day, after which they began to decline, showing an inverted U-shaped association. In males, a similar non-linear trend was observed for TG, with levels peaking at 3.0 cups/day before decreasing.…”

Image_2_The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study.JPEG by Wenyuan Gan (16900548)

“…</p>Result<p>515 patients with biopsy-proven PMN achieving initial remission were enrolled. 32.62% of patients subsequently relapsed during a median of 6.08 months. Lower serum albumin (Alb) (per 1 g/L decrease, hazard ratio [HR] =1.48, 95% confidence interval [CI] 1.29–1.78, p < 0.001), lower estimated glomerular filtration rate (eGFR) (per 10 mL/min/1.73m² decrease, HR =1.14, 95% CI 0.97–1.49, p < 0.001), higher serum complement 4 (C4) (per 0.1 g/L increase, HR =1.89, 95% CI 1.32–3.22, p = 0.012), partial remission (PR) (HR =2.28, 95%CI 1.74–4.04, p < 0.001), and treatment with calcineurin inhibitors (CINs) (HR =1.33, 95%CI 1.04–1.64, p < 0.001) at the time of remission were risk factors for relapse. …”

Image_3_The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study.JPEG by Wenyuan Gan (16900548)

“…</p>Result<p>515 patients with biopsy-proven PMN achieving initial remission were enrolled. 32.62% of patients subsequently relapsed during a median of 6.08 months. Lower serum albumin (Alb) (per 1 g/L decrease, hazard ratio [HR] =1.48, 95% confidence interval [CI] 1.29–1.78, p < 0.001), lower estimated glomerular filtration rate (eGFR) (per 10 mL/min/1.73m² decrease, HR =1.14, 95% CI 0.97–1.49, p < 0.001), higher serum complement 4 (C4) (per 0.1 g/L increase, HR =1.89, 95% CI 1.32–3.22, p = 0.012), partial remission (PR) (HR =2.28, 95%CI 1.74–4.04, p < 0.001), and treatment with calcineurin inhibitors (CINs) (HR =1.33, 95%CI 1.04–1.64, p < 0.001) at the time of remission were risk factors for relapse. …”

DataSheet_1_A Novel Treatment of Opioid Cravings With an Effect Size of .73 for Unilateral Transcranial Photobiomodulation Over Sham.docx by Fredric Schiffer (9256208)

“…</p>Results<p>Immediately after treatment the OCS improved significantly for both the sham and active treatments, but one week later the active treatment showed a 51.0% (SD 33.7) decrease in OCS while a week after the sham treatments there was a decrease of only 15.8% (SD 35.0) (by Wilcoxon Sign Rank Test, p = 0.004) and by a mixed model it was p = 0.0071. …”

Image_1_The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study.JPEG by Wenyuan Gan (16900548)

“…</p>Result<p>515 patients with biopsy-proven PMN achieving initial remission were enrolled. 32.62% of patients subsequently relapsed during a median of 6.08 months. Lower serum albumin (Alb) (per 1 g/L decrease, hazard ratio [HR] =1.48, 95% confidence interval [CI] 1.29–1.78, p < 0.001), lower estimated glomerular filtration rate (eGFR) (per 10 mL/min/1.73m² decrease, HR =1.14, 95% CI 0.97–1.49, p < 0.001), higher serum complement 4 (C4) (per 0.1 g/L increase, HR =1.89, 95% CI 1.32–3.22, p = 0.012), partial remission (PR) (HR =2.28, 95%CI 1.74–4.04, p < 0.001), and treatment with calcineurin inhibitors (CINs) (HR =1.33, 95%CI 1.04–1.64, p < 0.001) at the time of remission were risk factors for relapse. …”

Table_1_The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study.DOCX by Wenyuan Gan (16900548)

“…</p>Result<p>515 patients with biopsy-proven PMN achieving initial remission were enrolled. 32.62% of patients subsequently relapsed during a median of 6.08 months. Lower serum albumin (Alb) (per 1 g/L decrease, hazard ratio [HR] =1.48, 95% confidence interval [CI] 1.29–1.78, p < 0.001), lower estimated glomerular filtration rate (eGFR) (per 10 mL/min/1.73m² decrease, HR =1.14, 95% CI 0.97–1.49, p < 0.001), higher serum complement 4 (C4) (per 0.1 g/L increase, HR =1.89, 95% CI 1.32–3.22, p = 0.012), partial remission (PR) (HR =2.28, 95%CI 1.74–4.04, p < 0.001), and treatment with calcineurin inhibitors (CINs) (HR =1.33, 95%CI 1.04–1.64, p < 0.001) at the time of remission were risk factors for relapse. …”

Image_4_The association between serum complement 4 and relapse of primary membranous nephropathy: a multicenter retrospective cohort study.JPEG by Wenyuan Gan (16900548)

“…</p>Result<p>515 patients with biopsy-proven PMN achieving initial remission were enrolled. 32.62% of patients subsequently relapsed during a median of 6.08 months. Lower serum albumin (Alb) (per 1 g/L decrease, hazard ratio [HR] =1.48, 95% confidence interval [CI] 1.29–1.78, p < 0.001), lower estimated glomerular filtration rate (eGFR) (per 10 mL/min/1.73m² decrease, HR =1.14, 95% CI 0.97–1.49, p < 0.001), higher serum complement 4 (C4) (per 0.1 g/L increase, HR =1.89, 95% CI 1.32–3.22, p = 0.012), partial remission (PR) (HR =2.28, 95%CI 1.74–4.04, p < 0.001), and treatment with calcineurin inhibitors (CINs) (HR =1.33, 95%CI 1.04–1.64, p < 0.001) at the time of remission were risk factors for relapse. …”

GW788388 treatment decreases CD3⁺ cells number in the heart of mice chronically infected with <i>T</i>. <i>cruzi</i>. Mice were infected with <i>T</i>. <i>cruzi</i> from... by Roberto Rodrigues Ferreira (7109207)

Table_1_De novo LAMP2 insertion mutation causes cardiac-only Danon disease: A case report.xlsx by James Jiqi Wang (11736326)

“…Her family members do not carry the same mutation she does, suggesting this is a de novo mutation. Further tests revealed vacuoles and glycogen disposition in the patient's heart tissue and a significant decrease in LAMP2 protein expression. …”

Event-related time–frequency plots for all electrodes in subject A in response to presentation of proper names (targets in target detection task) by Ryan T. Canolty (86909)

“…Note HG activity in electrodes 8 and 15 over prefrontal cortex. See Figure A and methods for electrode locations. Vertical lines indicate stimulus onset and offset. …”

Acacetin inhibits 4-AP and KCl-evoked glutamate release from rat hippocampal nerve terminals in a concentration-dependent manner. by Tzu-Yu Lin (423761)

“…<p>A: Chemical structure of acacetin. B, C: Glutamate release was measured under control conditions or in the presence of 30 µM acacetin added 10 min prior to the addition of 4-AP (1 mM) or KCl (15 mM). …”

Increased mitochondrial mass determined by FACS analysis in control (WT) C2C12 clones exposed to Br-A23187. by Sylvie Ducreux (307645)

“…<p>A) FACS histogram of WT C2C12 cells treated for 48 h with Br-A23187 (1 µM) and loaded with Mito Tracker Green. …”

EWS results for the incidence of the Alpha-like pathogen, under a negative binomial reporting error, show successful anticipation of the epidemic transition. by Joshua Looker (21390948)

“…<p>Columns show new cases over time, effective reproduction number, variance between the mean-detrended simulations and time-of-detection distribution for the 10,000 simulations run for each of the four modelling scenarios (rows, constant , increasing , decreasing and a step-decrease in ) for the Alpha-like pathogen.…”

Image_1_De novo LAMP2 insertion mutation causes cardiac-only Danon disease: A case report.pdf by James Jiqi Wang (11736326)

“…Her family members do not carry the same mutation she does, suggesting this is a de novo mutation. Further tests revealed vacuoles and glycogen disposition in the patient's heart tissue and a significant decrease in LAMP2 protein expression. …”

Effects of (a) AG-490 and (b) WHI-P154 on IFN-γ-induced nitric oxide (NO) generation in J774 macrophages by Outi Sareila (66176)

Dynamic variations of cell populations given distinct impacts of Aβ on M1 macrophages (the value of α₁₃). by Ishwar K. Puri (358815)

“…<p>Variations in the (a) M₁, (b) N_d and (c) Aβ populations over 20 years for three values of α₁₃  =  1× (black), 10× (red), and 50× (blue) the value reported in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015176#pone-0015176-t001" target="_blank">Table 1</a> for the path Aβ → M₁. …”

Time –dependent spectral changes in the emission spectra of the SITS-labeled αA- crystallins interacting with LYI- labeled βL- crystallin. by Anbarasu Kumarasamy (91284)

“…The decrease in fluorescence intensity at 426 nm of SITS-labeled αA- crystallins and concomitant increase in fluorescence intensity at 515 nm of LYI- labeled ADH is indicative of energy transfer due to exchange of subunits between the two labeled proteins.…”

<i>Grin2b</i>^<i>+/–</i>mice display decreased GluN2B levels and hypoactivity and anxiolytic-like behavior, similar to <i>Grin2b</i>^{<i>+/C456Y</i>} mice. by Wangyong Shin (6793040)

“…<p>(A and B) Decreased levels of the GluN2B, but not GluN1 or GluN2A, protein in the <i>Grin2b</i>^<i>+/–</i>mice brain. …”

MARCKS knockdown decreases p27^kip1, pSer10-p27^kip1, KIS, cyclin D1, and ubiquitin ligase E3 Skp2, but does not affect cyclin E1 protein expression. by Dan Yu (214174)

“…KIS and pSer10-p27^kip1 had the greatest decrease in protein expression as a result of MARCKS knockdown. …”